Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System

Title:Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System

Volume: 5 Issue: 3

Author(s): Frank Roesch

Affiliation:

Keywords: Titanium-44, Scandium-44, Radionuclide generator, Post-processing, DOTA, Octreotide, Positron emission, PET, COST

Abstract: 44Ti/44Sc radionuclide generators are of interest for molecular imaging. The 3.97 hours half-life of 44Sc and its high positron branching of 94.27% may stimulate the application of 44Sc-labeled PET radiopharmaceuticals. This review describes the current status of 44Ti production, 44Ti/44Sc radionuclide generator development, post-processing of generator eluates towards medical application, identification of ligands adequate to ScIII co-ordination chemistry, proof-of-principle labeling of 44Sc-DOTA-octreotides, investigation of in vitro and in vivo parameters, and initial applications for molecular imaging – both in small animals and humans.

Cite this article as:

Roesch Frank, Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the 44Ti/44Sc Generator System, Current Radiopharmaceuticals 2012; 5 (3) . https://dx.doi.org/10.2174/1874471011205030187